Mitsubishi Electric Corporation (TYO:6503)

Verve Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	821,783	757,331	765,384	645,870	727,179	767,406
Cash & Short-Term Investments	821,783	757,331	765,384	645,870	727,179	767,406
Cash Growth	0.68%	-1.05%	18.50%	-11.18%	-5.24%	42.76%
Receivables	1,324,284	1,490,265	1,408,534	1,051,641	944,405	906,831
Inventory	1,273,910	1,244,959	1,253,493	1,209,254	959,660	743,782
Other Current Assets	264,962	254,980	197,825	481,422	459,052	428,953
Total Current Assets	3,684,939	3,747,535	3,625,236	3,388,187	3,090,296	2,846,972
Property, Plant & Equipment	958,897	958,458	962,608	896,313	855,746	857,645
Long-Term Investments	313,049	324,766	265,698	952,977	840,522	756,658
Goodwill	-	104,647	99,426	90,703	69,123	61,109
Other Intangible Assets	233,328	116,759	112,438	99,898	92,371	92,403
Long-Term Deferred Tax Assets	109,554	113,146	113,967	154,441	159,915	183,134
Other Long-Term Assets	1,001,355	1,010,369	987,967	-	-	-
Total Assets	6,301,122	6,375,680	6,167,340	5,582,519	5,107,973	4,797,921
Accounts Payable	566,038	601,978	589,142	644,456	601,606	541,774
Accrued Expenses	302,280	363,875	347,698	332,788	326,703	302,418
Short-Term Debt	-	-	-	87,492	74,963	72,052
Current Portion of Long-Term Debt	122,395	65,629	98,823	-	-	20,000
Current Portion of Leases	-	55,260	52,875	98,812	98,250	60,605
Current Income Taxes Payable	35,710	42,698	66,930	46,617	33,575	30,959
Current Unearned Revenue	375,406	330,616	306,094	-	-	-
Other Current Liabilities	363,940	386,973	377,625	592,661	511,625	477,573
Total Current Liabilities	1,765,769	1,847,029	1,839,187	1,802,826	1,646,722	1,505,381
Long-Term Debt	238,475	148,550	142,467	164,773	142,208	156,845
Long-Term Leases	-	91,222	100,471	49,681	14,040	55,929
Long-Term Unearned Revenue	-	19,605	20,237	-	-	-
Long-Term Deferred Tax Liabilities	25,874	25,155	22,264	7,762	4,774	5,759
Other Long-Term Liabilities	43,892	24,077	25,336	40,432	40,479	42,008
Total Liabilities	2,220,171	2,299,314	2,300,922	2,219,295	2,010,576	1,927,310
Common Stock	175,820	175,820	175,820	175,820	175,820	175,820
Additional Paid-In Capital	186,385	186,741	195,157	202,888	202,695	202,777
Retained Earnings	3,336,839	3,304,481	3,102,755	2,636,136	2,464,966	2,266,490
Treasury Stock	-99,870	-71,823	-98,040	-52,715	-52,068	-2,595
Comprehensive Income & Other	354,138	354,459	363,632	276,898	184,528	111,801
Total Common Equity	3,953,312	3,949,678	3,739,324	3,239,027	2,975,941	2,754,293
Minority Interest	127,639	126,688	127,094	124,197	121,456	116,318
Shareholders' Equity	4,080,951	4,076,366	3,866,418	3,363,224	3,097,397	2,870,611
Total Liabilities & Equity	6,301,122	6,375,680	6,167,340	5,582,519	5,107,973	4,797,921
Total Debt	360,870	360,661	394,636	400,758	329,461	365,431
Net Cash (Debt)	460,913	396,670	370,748	245,112	397,718	401,975
Net Cash Growth	8.97%	6.99%	51.26%	-38.37%	-1.06%	150.36%
Net Cash Per Share	222.09	190.57	176.61	116.07	186.48	187.38
Filing Date Shares Outstanding	2,075	2,075	2,099	2,110	2,112	2,145
Total Common Shares Outstanding	2,075	2,075	2,099	2,112	2,112	2,145
Working Capital	1,919,170	1,900,506	1,786,049	1,585,361	1,443,574	1,341,591
Book Value Per Share	1904.86	1903.11	1781.26	1533.98	1409.08	1283.88
Tangible Book Value	3,719,984	3,728,272	3,527,460	3,048,426	2,814,447	2,600,781
Tangible Book Value Per Share	1792.43	1796.42	1680.33	1443.71	1332.62	1212.32
Land	-	110,682	121,283	-	-	-
Buildings	-	1,163,114	1,169,158	-	-	-
Machinery	-	2,360,724	2,335,873	-	-	-
Construction In Progress	-	128,154	119,834	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.